2025 annual financial data
Apogee Therapeutics 2025 Operating margin
Apogee Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -285,595,000 USD and net income was -255,843,000 USD.
Operating cash flow was -227,450,000 USD.
Get free Apogee Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -285,595,000 USD
- Net income
- -255,843,000 USD
- Operating cash flow
- -227,450,000 USD